Service of General Surgery, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Cir Cir. 2021;89(1):89-96. doi: 10.24875/CIRU.20000055.
Biliopleural fistula is a rare communication between the biliary system and the pleural space secondary to ruptured hydatid cysts, hepatobiliary surgeries or penetrating wounds. There is not so much of the subject in the literature, so there is no standardized protocol for its management.
The objective of this work is to determine advantages and disadvantages of the use of ERCP as a conservative initial treatment for biliopleural fistulas.
Our retrospective study included patients with a diagnosis of biliopleural fistula who underwent ERCP as initial treatment, older than 18 years in a period from August 2016 to August 2019.
Eight patients with a diagnosis of biliopleural fistula were included, 75% men and 25% women with a mean age of 24.5 years; the traumatic etiology was predominant in our group (89%), the diagnosis was made between days 3 and 14 after chest tube placement and we were successful in treating the fistula with ERCP in 87.5% of our patients.
The use of ERCP as initial treatment for biliopleural fistula should be considered as the initial tool in the algorithm of management of this entity.
由于肝包虫囊肿破裂、肝胆手术或穿透性损伤,导致胆系和胸膜腔之间发生罕见的交通,即胆胸膜瘘。由于文献中对此类疾病的报道较少,因此其管理尚无标准化方案。
本研究旨在确定 ERCP 作为胆胸膜瘘初始保守治疗的优缺点。
本回顾性研究纳入了 2016 年 8 月至 2019 年 8 月期间接受 ERCP 初始治疗的胆胸膜瘘患者,患者年龄均大于 18 岁。
本研究共纳入 8 例胆胸膜瘘患者,其中男性占 75%,女性占 25%,平均年龄为 24.5 岁;本组患者以创伤性病因为主(89%),诊断均在放置胸腔引流管后 3 至 14 天内做出,87.5%的患者通过 ERCP 成功治疗了瘘管。
对于胆胸膜瘘患者,应考虑将 ERCP 作为初始治疗作为该疾病管理方案的初始工具。